Vector rearrangement boosts globin-delivering gene therapies

NIH vector rearrangement boosts production, transduction efficiencies of lentiviral β globin delivery

Through vector genome reorganization, NIH researchers have amplified the manufacturing output and β globin delivery for a lentiviral gene therapy for sickle cell disease and β thalassemia.

According to Naoya Uchida, gene therapies delivering β globin (HBB) have been "reverse-oriented" -- arranged

Read the full 418 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE